(688278)"Xiamen Amoytop Biotech Co., Ltd."Risk Warning Announcement on the Suitability Requirements for Convertible Bond Investors
Filed with SSE · Stock code 688278 · · 2 pages · Chinese
Summary by 6ix AI
The announcement details the issuance and listing of the convertible bonds, including their conversion period. It highlights the risk that investors who do not meet the suitability requirements for the Sci-Tech Innovation Board cannot convert their bonds into shares. Investors are advised to be aware of the implications of not meeting these requirements.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Xiamen Amoytop Biotech Co., Ltd. on 6ix
Earlier from Xiamen Amoytop Biotech
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Progress in Repurchasing Shares
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Satisfaction of Vesting Conditions for the Second Vesting Period of the Initial Grant and the First Vesting Period of the Reserved Grant under the 2024 Restricted Share Incentive Plan
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Resolutions of the 25th Meeting of the 9th Board of Directors
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Cancellation of Certain Granted but Unvested Restricted Shares under the 2024 Restricted Share Incentive Plan
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Adjustment of the Grant Price under the 2024 Restricted Share Incentive Plan
Later from Xiamen Amoytop Biotech
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Progress of Joint Investment with Related Parties and Related Party Transactions
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Voluntary Commitment by Actual Controllers and Person Acting in Concert Not to Reduce Shareholdings in the Company
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Voluntary Commitment by Shareholder Holding More Than 5% of the Shares Not to Reduce Shareholdings in the Company
- (688278)"Xiamen Amoytop Biotech Co., Ltd."Report for Q3 2026
Follow Xiamen Amoytop Biotech into a list and get an email when it puts out news.
Follow Xiamen Amoytop Biotech